Impact of Istradefylline on Levodopa Dose Escalation in Parkinson’s Disease: ISTRA ADJUST PD Study, a Multicenter, Open-Label, Randomized, Parallel-Group Controlled Study

被引:0
|
作者
Taku Hatano
Renpei Sengoku
Hiroshi Nagayama
Naotake Yanagisawa
Asako Yoritaka
Keisuke Suzuki
Noriko Nishikawa
Yohei Mukai
Kyoichi Nomura
Norihito Yoshida
Morinobu Seki
Miho Kawabe Matsukawa
Hiroo Terashi
Katsuo Kimura
Jun Tashiro
Shigeki Hirano
Hidetomo Murakami
Hideto Joki
Tsuyoshi Uchiyama
Hideki Shimura
Kotaro Ogaki
Jiro Fukae
Yoshio Tsuboi
Kazushi Takahashi
Toshimasa Yamamoto
Kenichi Kaida
Ryoko Ihara
Kazutomi Kanemaru
Osamu Kano
机构
[1] Juntendo University,Department of Neurology, Faculty of Medicine
[2] Daisan Hospital,Department of Neurology
[3] The Jikei University School of Medicine,Department of Neurology
[4] Nippon Medical School,Medical Technology Innovation Center
[5] Juntendo University and Juntendo Clinical Research and Trial Center,Department of Neurology
[6] Juntendo University Koshigaya Hospital,Department of Neurology
[7] Dokkyo Medical University Hospital,Department of Neurology
[8] National Center of Neurology and Psychiatry,Department of Neurology
[9] Higashimatsuyama Municipal Hospital,Department of Neurology
[10] Saitama Medical Center,Department of Neurology
[11] Saitama Medical University,Department of Neurology
[12] Keio University School of Medicine,Department of Neurology
[13] Tokyo Metropolitan Institute for Geriatrics and Gerontology,Department of Neurology
[14] Tokyo Medical University,Department of Neurology, Graduate School of Medicine
[15] Yokohama City University Medical Center,Department of Neurology
[16] Sapporo Parkinson MS Neurological Clinic,Department of Neurology and Stroke Medicine
[17] Chiba University,Department of Neurology
[18] The Jikei University School of Medicine,Department of Neurology
[19] Yokohama City University Graduate School of Medicine,Department of Neurology
[20] Seirei Hamamatsu General Hospital,Department of Neurology
[21] Juntendo Tokyo Koto Geriatric Medical Center,Department of Neurology
[22] Juntendo University Urayasu Hospital,Department of Neurology
[23] Juntendo University Nerima Hospital,Department of Neurology
[24] Fukuoka University,Department of Neurology
[25] Tokyo Metropolitan Neurological Hospital,Department of Neurology
[26] Saitama Medical University,Department of Neurology
[27] Toho University,undefined
[28] Faculty of Medicine,undefined
[29] National Hospital Organization Yokohama Medical Center,undefined
[30] Juntendo University Koshigaya Hospital,undefined
来源
Neurology and Therapy | 2024年 / 13卷
关键词
Adenosine A; receptor antagonist; Istradefylline; Levodopa; Levodopa dose; Parkinson’s disease;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:323 / 338
页数:15
相关论文
共 50 条
  • [1] Impact of Istradefylline on Levodopa Dose Escalation in Parkinson's Disease: ISTRA ADJUST PD Study, a Multicenter, Open-Label, Randomized, Parallel-Group Controlled Study
    Hatano, Taku
    Sengoku, Renpei
    Nagayama, Hiroshi
    Yanagisawa, Naotake
    Yoritaka, Asako
    Suzuki, Keisuke
    Nishikawa, Noriko
    Mukai, Yohei
    Nomura, Kyoichi
    Yoshida, Norihito
    Seki, Morinobu
    Matsukawa, Miho Kawabe
    Terashi, Hiroo
    Kimura, Katsuo
    Tashiro, Jun
    Hirano, Shigeki
    Murakami, Hidetomo
    Joki, Hideto
    Uchiyama, Tsuyoshi
    Shimura, Hideki
    Ogaki, Kotaro
    Fukae, Jiro
    Tsuboi, Yoshio
    Takahashi, Kazushi
    Yamamoto, Toshimasa
    Kaida, Kenichi
    Ihara, Ryoko
    Kanemaru, Kazutomi
    Kano, Osamu
    [J]. NEUROLOGY AND THERAPY, 2024, 13 (02) : 323 - 338
  • [2] Impact of Istradefylline on Levodopa Dose Escalation in Parkinson's Disease: Results of the ISTRA ADJUST PD Randomized, Controlled Study
    Hatano, Taku
    Kano, Osamu
    Sengoku, Renpei
    Yanagisawa, Naotake
    Nagayama, Hiroshi
    [J]. NEUROLOGY, 2023, 100 (17)
  • [3] Impact of istradefylline on the adjustment of levodopa dose escalation in Parkinson's disease: Results of the ISTRA ADJUST PD randomized, controlled study
    Hatano, T.
    Kano, O.
    Sengoku, R.
    Yanagisawa, N.
    Nagayama, H.
    [J]. MOVEMENT DISORDERS, 2022, 37 : S331 - S331
  • [4] Evaluating the impact of adjunctive istradefylline on the cumulative dose of levodopa-containing medications in Parkinson's disease: study protocol for the ISTRA ADJUST PD randomized, controlled study
    Hatano, Taku
    Kano, Osamu
    Sengoku, Renpei
    Yoritaka, Asako
    Suzuki, Keisuke
    Nishikawa, Noriko
    Mukai, Yohei
    Nomura, Kyoichi
    Yoshida, Norihito
    Seki, Morinobu
    Matsukawa, Miho Kawabe
    Terashi, Hiroo
    Kimura, Katsuo
    Tashiro, Jun
    Hirano, Shigeki
    Murakami, Hidetomo
    Joki, Hideto
    Uchiyama, Tsuyoshi
    Shimura, Hideki
    Ogaki, Kotaro
    Fukae, Jiro
    Tsuboi, Yoshio
    Takahashi, Kazushi
    Yamamoto, Toshimasa
    Yanagisawa, Naotake
    Nagayama, Hiroshi
    [J]. BMC NEUROLOGY, 2022, 22 (01)
  • [5] Evaluating the impact of adjunctive istradefylline on the cumulative dose of levodopa-containing medications in Parkinson’s disease: study protocol for the ISTRA ADJUST PD randomized, controlled study
    Taku Hatano
    Osamu Kano
    Renpei Sengoku
    Asako Yoritaka
    Keisuke Suzuki
    Noriko Nishikawa
    Yohei Mukai
    Kyoichi Nomura
    Norihito Yoshida
    Morinobu Seki
    Miho Kawabe Matsukawa
    Hiroo Terashi
    Katsuo Kimura
    Jun Tashiro
    Shigeki Hirano
    Hidetomo Murakami
    Hideto Joki
    Tsuyoshi Uchiyama
    Hideki Shimura
    Kotaro Ogaki
    Jiro Fukae
    Yoshio Tsuboi
    Kazushi Takahashi
    Toshimasa Yamamoto
    Naotake Yanagisawa
    Hiroshi Nagayama
    [J]. BMC Neurology, 22
  • [6] Caffeine in Parkinson's disease: A pilot open-label, dose-escalation study
    Altman, Robert D.
    Lang, Anthony E.
    Postuma, Ronald B.
    [J]. MOVEMENT DISORDERS, 2011, 26 (13) : 2427 - 2431
  • [7] Exenatide, Metformin, or Both for Prediabetes in PCOS: A Randomized, Open-label, Parallel-group Controlled Study
    Tao, Tao
    Zhang, Yi
    Zhu, Yu-Chen
    Fu, Jia-Rong
    Wang, Yu-Ying
    Cai, Jie
    Ma, Jing-Yu
    Xu, Yu
    Gao, Yi-Ning
    Sun, Yun
    Fan, WuQiang
    Liu, Wei
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2021, 106 (03): : E1420 - E1432
  • [8] Open-label, parallel-group, multicenter, randomized study of cefprozil versus erythromycin in children with group A streptococcal pharyngitis/tonsillitis
    Brook, I
    Aronovitz, GH
    Pichichero, ME
    [J]. CLINICAL THERAPEUTICS, 2001, 23 (11) : 1889 - 1900
  • [9] EFFECTS OF ISTRADEFYLLINE FOR QUALITY OF LIFE IN PARKINSON'S DISEASE WITH FREEZING OF GAIT: A SINGLEARM, OPEN-LABEL, PROSPECTIVE, MULTICENTER STUDY
    Iijima, M.
    Orimo, S.
    Terashi, H.
    Suzuki, M.
    Hayashi, A.
    Shimura, H.
    Kitagawa, K.
    Okuma, Y.
    [J]. PARKINSONISM & RELATED DISORDERS, 2020, 79 : E72 - E72
  • [10] Replacing a Dopamine Agonist by the COMT-Inhibitor Tolcapone as an Adjunct to L-dopa in the Treatment of Parkinson's Disease: A Randomized, Multicenter, Open-Label, Parallel-Group Study
    Ries, Vincent
    Selzer, Roland
    Eichhorn, Tobias
    Oertel, Wolfgang H.
    Eggert, Karla
    [J]. CLINICAL NEUROPHARMACOLOGY, 2010, 33 (03) : 142 - 150